<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2343">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04362956</url>
  </required_header>
  <id_info>
    <org_study_id>Perinatal COVID-19</org_study_id>
    <nct_id>NCT04362956</nct_id>
  </id_info>
  <brief_title>Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection</brief_title>
  <official_title>Clinical and Immunologic Impact of SARS-CoV-2 in Hospitalized Pregnant Women and Neonates in Argentina</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion Infant</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion Infant</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center prospective study that aims to investigate the clinical and
      immunologic impact of SARS-CoV-2 infection in pregnant women and neonates. The goal is to
      recruit 200 SARS-CoV-2 infected pregnant women starting at 24 weeks of gestation in a
      neonatal network of 45.000 birth a year. Clinical data will be collected from women and
      neonates. Upper airways samples will be obtained from both for bio-markers investigation.
      Finally, maternal and umbilical cord serum and human milk will be obtained for antibody
      assessment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, has led to an unprecedented
      global pandemic affecting persons of all ages. Pregnant women are in a physiologic
      immunosuppressed situation and have a greater risk and severity of respiratory infection.
      However, considerable uncertainty exists regarding the potential for vertical transmission
      (prenatal/congenital or perinatal) of SARS-CoV-2 from infected pregnant women to their
      newborns and its potential clinical consequences.

      This study attempts to provide evidence-based guidelines for managing antenatal, intrapartum,
      and neonatal care around COVID-19 require an understanding of whether the virus can be
      transmitted transplacentally; a determination of which maternal body fluids may be
      infectious; and data of adequate statistical power that describe which maternal, intrapartum,
      and neonatal factors influence perinatal transmission.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 10, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vertical transmission</measure>
    <time_frame>96 hours from birth</time_frame>
    <description>Presence of IgM in Umbilical Cord or presence of virus in human milk with infected neonate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neonatal protection due to maternal antibodies</measure>
    <time_frame>24 weeks of gestation to birth</time_frame>
    <description>Presence of IgG in umbilical cord</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase risk of neonatal morbidity</measure>
    <time_frame>up to 30 days of life</time_frame>
    <description>Respiratory distress, hypothermia, poor feeding and others</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase risk of obstetric complications</measure>
    <time_frame>Up to 14 days of hospitalization</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Covid19</condition>
  <condition>Pregnancy Related</condition>
  <condition>Neonatal Infection</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Nasopharyngeal aspirates Maternal serum Umbilical Cord serum Human milk
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Elegible patients will be all pregnant women of 9 large maternity hospitals in Argentina.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women hospitalized presenting with:

               1. Fever with one or more respiratory symptoms (cough, odinophagia, respiratory
                  difficulty)

               2. Diagnoses of pneumonia with no other explainable cause.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Gaston Ofman, MD</last_name>
    <phone>01154911-4078-1550</phone>
    <email>gofman@infant.org.ar</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Italiano</name>
      <address>
        <city>Buenos Aires</city>
        <zip>1420</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gonzalo Mariani, MD</last_name>
      <phone>4959-0200 i</phone>
      <email>gonzalo.mariani@hospitalitaliano.org.ar</email>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>April 21, 2020</study_first_submitted>
  <study_first_submitted_qc>April 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2020</study_first_posted>
  <last_update_submitted>August 27, 2020</last_update_submitted>
  <last_update_submitted_qc>August 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundacion Infant</investigator_affiliation>
    <investigator_full_name>Gaston Ofman</investigator_full_name>
    <investigator_title>Head of Perinatal Research</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

